MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (HTFL), the leader in AI technology for coronary artery disease (CAD), announced two new analyses from FISH&CHIPS, a real-world ...
MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...
MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of Cardiology (ACC) and ...
MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque ...
Holy Cross Medical Center is expanding heart care for northern New Mexico residents with the introduction of HeartFlow Plaque Analysis, an advanced, non-invasive technology that helps doctors better u ...
The MarketWatch News Department was not involved in the creation of this content. MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary ...
Heartflow, Inc. has announced that UnitedHealthcare will cover its Heartflow Plaque Analysis across all business lines, making it the first insurer to align its policies with new guidelines from ...
Hosted on MSN
HeartFlow sets sights on $300m IPO
HeartFlow has revealed plans to raise up to $300m in an initial public offering (IPO). The Bain Capital-backed AI-based coronary artery disease (CAD) platform developer filed a Form S-1 with the US ...
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results